Pengaruh Terapi ARV untuk Meningkatkan Kualitas Hidup Pasien HIV/AIDS: A Literature Review

  • Siska Mutiara Hikmah S Jurusan Keperawatan Universitas Jenderal Soedirman
  • Hasri Kuswiharyanti Jurusan Keperawatan Universitas Jenderal Soedirman
  • Vidi Ahmad Raafi Jurusan Keperawatan Universitas Jenderal Soedirman
  • Ninik Juarti Jurusan Keperawatan Universitas Jenderal Soedirman
  • Tria Amaliadiana Jurusan Keperawatan Universitas Jenderal Soedirman
Keywords: Terapi ARV; Pasien HIV/AIDS

Abstract

INTRODUCTION : Acquired immunodeficiency syndrome (AIDS) is a collection of disease symptoms that attack human body after HIV (Human Immunodeficiency Virus) damage the immune system.  HIV-AIDS is a disease that cannot be cured now, but there are therapies to help improve the quality of life for people with HIV, and also to increase the antibodies for people with HIV and the therapy is called ARV. The main goal of ARV treatment is to reduce the number of HIV viruses to delay and stop the growth of the virus.

METHOD : Determine the latest intervention regarding evidence based on HIV-AIDS and ARV pharmacological therapy. After determining the topic, the next step is to search for literatures that will be reviewed, the literatures are in the form of scientific journals obtained from databases such as: Science Direct, ProQuest, and Google Scholar with keyword: “ARV for HIV/AIDS†for international journals and for the national journals using Google search engine from 2014-2019.

RESULT : Based on journals as a literature, the conclusion is that ARV therapy can improve the quality of life for people with HIV-AIDS, the characteristic of the therapy is to form the antibodies and produce proinflamation agents to reduce the growth of the viruses, beside that the therapy is also effective  if it given directly to HIV-AIDS patients who early diagnosed as a HIV-AIDS patient, and also the ARV therapy can improve the quality life of children and reduce the risk of HIV-AIDS in children who have mothers with HIV-AIDS.

CONCLUSION : ARV therapy can improve the quality of life and prevent the transmission from mothers with HIV to their children.

References

KemenKes RI. 2011. Pedoman Nasional Pencegahan Penularan HIV dari Ibu ke Bayi. Jakarta.
KemenKes RI. 2017. Laporan Perkembangan HIV-AIDS & Penyakit Infeksi Menular Seksual (PIMS) Triwulan I. Jakarta
LPPSLH. 2017. Pentingnya VCT untuk Mendeteksi HIVSejak Dini, diakses dari http://www.lppslh.or.id/artikel/pentingnya-vct-untuk-mengetahui-status-hiv-sejak-dini/ Pada 29 Mei 2019
Chen, W. T. et al. (2013) ‘Antiretroviral therapy (ART) side effect impacted on quality of life, and depressive symptomatology: A mixed-method study’, Journal of AIDS and Clinical Research, 4(6). doi: 10.4172/2155-6113.1000218.
Karyadi, T. (2017) ‘Keberhasilan Pengobatan Antiretroviral ( ARV )’, Jurnal Penyakit Dalam Indonesia, 4(1), pp. 2–4.
Saag, M. S. et al. (2018) ‘Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel’, JAMA - Journal of the American Medical Association, 320(4), pp. 379–396. doi: 10.1001/jama.2018.8431.
Wahyudi, H. et al. (2013) ‘Terapi ARV Meningkatkan Kadar IL-17 Serum pada Pasien HIV ARV Treatment Increase IL-17 Serum Level in HIV Patients’, Jurnal Kedokteran Brawijaya, 27(4), pp. 222–227.
Yuliandra, Y. et al. (2017) ‘Terapi Antiretroviral pada Pasien HIV/AIDS di RSUP. Dr. M. Djamil Padang: Kajian Sosiodemografi dan Evaluasi Obat’, Jurnal Sains Farmasi & Klinis, 4(1), p. 1. doi: 10.29208/jsfk.2017.4.1.173.
Zhang, S. et al. (2013) ‘Racial/ethnic disparities in antiretroviral treatment among HIV-infected pregnant medicaid enrollees, 2005-2007’, American Journal of Public Health, 103(12), pp. 2005–2007. doi: 10.2105/AJPH.2013.301328.
Published
2021-05-31
How to Cite
Siska Mutiara Hikmah S, Hasri Kuswiharyanti, Vidi Ahmad Raafi, Ninik Juarti, & Tria Amaliadiana. (2021). Pengaruh Terapi ARV untuk Meningkatkan Kualitas Hidup Pasien HIV/AIDS: A Literature Review. Journal of Bionursing, 3(2), 134-145. https://doi.org/10.20884/1.bion.2021.3.2.101